Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › ETVAX

ETVAX

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of ETVAX

2 trials tracked of ETVAX.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 2
  1. Phase 2 Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh Completed
  2. Phase 2 A Phase 2 Bridging Study to Assess the New Formulation of ETVAX Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
ETVAX shows 48.2% efficacy against moderate-to-severe ETEC diarrhoea in Gambian children despite missing primary endpoint
Drug Pipeline RCT
ETVAX shows 48.2% efficacy against moderate-to-severe ETEC diarrhoea in Gambian children despite missing primary endpoint Early trial shows ETVAX vaccine linked to reduced diarrhoea in Gambian children
This phase 2b randomized controlled trial enrolled 4936 Gambian children aged 6 to 18 months. ETVAX demonstrated 48.2% efficacy against mode…
A phase 2b trial found an ETEC vaccine linked to lower diarrhoea rates in young children, though the main goal was not reached.
Jun 5, 2026